Seres I - Search Results

1

Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects.

Lőrincz H, Csige I, Harangi M, Szentpéteri A, Seres I, Szabó Z, Paragh G, Somodi S. Lőrincz H, et al. Among authors: seres i. Life (Basel). 2021 Aug 27;11(9):881. doi: 10.3390/life11090881. Life (Basel). 2021. PMID: 34575030 Free PMC article.

2

The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia.

Paragh G, Seres I, Balogh Z, Varga Z, Kárpáti I, Mátyus J, Ujhelyi L, Kakuk G. Paragh G, et al. Among authors: seres i. Nephron. 1998 Oct;80(2):166-70. doi: 10.1159/000045161. Nephron. 1998. PMID: 9736814

3

Altered signal pathway in granulocytes from patients with hypercholesterolemia.

Paragh G, Kovács E, Seres I, Keresztes T, Balogh Z, Szabó J, Teichmann F, Fóris G. Paragh G, et al. Among authors: seres i. J Lipid Res. 1999 Sep;40(9):1728-33. J Lipid Res. 1999. PMID: 10484621 Free article.

4

Serum paraoxonase activity changes in uremic and kidney-transplanted patients.

Paragh G, Asztalos L, Seres I, Balogh Z, Löcsey L, Kárpáti I, Mátyus J, Katona E, Harangi M, Kakuk G. Paragh G, et al. Among authors: seres i. Nephron. 1999;83(2):126-31. doi: 10.1159/000045489. Nephron. 1999. PMID: 10516491 Clinical Trial.

5

Which parameters affect cytosolic free calcium in polymorphonuclear leukocytes of haemodialysis patients?

Kárpáti I, Seres I, Mátyus J, Ben T, Paragh G, Varga Z, Kakuk G. Kárpáti I, et al. Among authors: seres i. Nephrol Dial Transplant. 2001 Jul;16(7):1409-15. doi: 10.1093/ndt/16.7.1409. Nephrol Dial Transplant. 2001. PMID: 11427633 Clinical Trial.

6

Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?

Balogh Z, Seres I, Harangi M, Kovács P, Kakuk G, Paragh G. Balogh Z, et al. Among authors: seres i. Diabetes Metab. 2001 Nov;27(5 Pt 1):604-10. Diabetes Metab. 2001. PMID: 11694861 Clinical Trial.

7

Determination of DNA damage induced by oxidative stress in hyperlipidemic patients.

Harangi M, Remenyik E E, Seres I, Varga Z, Katona E, Paragh G. Harangi M, et al. Among authors: seres i. Mutat Res. 2002 Jan 15;513(1-2):17-25. doi: 10.1016/s1383-5718(01)00285-6. Mutat Res. 2002. PMID: 11719086

8

[Changes in lipid profile and paraoxonase activity in obese patients as a result of orlistat treatment].

Audikovszky M, Pados G, Seres I, Harangi M, Fülöp P, Katona E, Winkler G, Paragh G. Audikovszky M, et al. Among authors: seres i. Orv Hetil. 2001 Dec 16;142(50):2779-83. Orv Hetil. 2001. PMID: 11820148 Clinical Trial. Hungarian.

9

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.

Paragh G, Balla P, Katona E, Seres I, Egerházi A, Degrell I. Paragh G, et al. Among authors: seres i. Eur Arch Psychiatry Clin Neurosci. 2002 Apr;252(2):63-7. doi: 10.1007/s004060200013. Eur Arch Psychiatry Clin Neurosci. 2002. PMID: 12111338

10

The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.

Paragh G, Seres I, Harangi M, Balogh Z, Illyés L, Boda J, Szilvássy Z, Kovács P. Paragh G, et al. Among authors: seres i. Diabetes Metab. 2003 Dec;29(6):613-8. doi: 10.1016/s1262-3636(07)70077-0. Diabetes Metab. 2003. PMID: 14707891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters